share_log

Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Aisling Capital IV, LP(5.46%),Steve Elms(5.46%), etc.

Mar 3, 2023 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more